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Following intraperitoneal (IP) inoculation of neonatal mice, the polytropic recombinant murine leukemia virus (MuLV), Fr98,
induces a severe brain disease characterized by ataxia, seizures and death. In contrast, no apparent clinical neurological
disease is seen after IP infection with Fr54, a polytropic MuLV differing from Fr98 in its envelope gene sequences. In the brain
both Fr98 and Fr54 infect primarily capillary endothelial cells and microglia. However, the level of microglial infection by Fr98
is twofold higher than by Fr54, which might account for the difference in neurovirulence. In the present study, in order to test
directly whether an increase in the number of microglia infected by Fr54 would be sufficient to induce clinical disease, we
attempted to increase the level of Fr54 in the brain by changing the route of infection. After intraventricular inoculation with
Fr54-infected neural stem cells (clone C17.2), a well-established vehicle for delivery of viruses and genes to the brain, mice
became ataxic and died 4 weeks postinfection. In these mice induction of brain disease was correlated with a higher level
of viral antigen in the cerebrum and an increase in the number of infected microglial cells in all brain regions examined
compared with mice inoculated IP. In contrast, mice inoculated with neural stem cells infected with an ecotropic nonneu-
rovirulent murine leukemia virus, FB29, developed no clinical disease in spite of evidence for widespread infection of
microglia in brain. Since the main differences between Fr54 and FB29 are in the SU (gp70) region of the envelope gene, this
region is most likely to account for the differences in induction of CNS disease seen in the current experiments. © 1999
Academic Press
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Retrovirus infection of the CNS causes neurological
isease in a variety of species. Clinical manifestations
ange from acute encephalitis to neuromotor deficits and
ognitive impairment (Gardner et al., 1973; Price and
rew, 1988; McArthur et al., 1993; Georgsson, 1994;
zumo et al., 1997). The pathogenic mechanisms respon-
ible for these diseases remain unclear. For both lenti-
iruses and also some models of murine leukemia virus
MuLV)-induced brain disease, microglial cells, rather
han neurons, appear to be important sites of viral infec-
ion (Koenig et al., 1986; Jordan et al., 1991; Lynch et al.,
991; Robertson et al., 1997; Kodama et al., 1993; Gravel
t al., 1993; Lane et al., 1995). In these diseases the
eurological impairment appears to result from indirect
ffects of infected microglia on the function of nearby
ninfected neurons (Gendelman et al., 1994; Lipton, 1991;
ynch et al., 1991).
The pathogenesis of retroviral brain diseases can be
nfluenced by both host and viral genes. In the case of the
olytropic Friend murine leukemia virus, FMCF98, which
auses severe ataxia and seizures, we have previously
1 Current address: Thomas Jefferson University, CNS Gene Therapy
ienter, 1025 Walnut, Suite 511, College Building, Philadelphia, PA 19107.
23dentified two host genes (Buller et al., 1990) and several
iral genes (Hasenkrug et al., 1996; Portis et al., 1995),
hich influence development of CNS disease. The env
ene of FMCF98 was found to be particularly important for
eurovirulence. When this env gene was inserted into a
onneurovirulent MuLV, the resulting chimeric virus, Fr98,
as capable of inducing ataxia and death (Portis et al.,
995), whereas Fr54, which differs from Fr98 at only a small
umber of amino acid residues in the envelope gene,
aused no clinical disease (Hasenkrug et al., 1996). Both
r98 and Fr54 were found to infect brain capillary endothe-
ial cells and microglia cells, and the ability of Fr98 to cause
linical disease was correlated with a twofold increase in
he number of infected microglia (Robertson et al., 1997).
herefore, in the present studies we tested the hypothesis
hat Fr54 itself might be capable of induction of clinical CNS
isease if the level of infection in brain parenchyma could
e increased. Instead of using IP inoculation as was done
arlier, we infected neonatal mice by intraventricular trans-
lantation of Fr54-infected cells. For this purpose we used
he C17.2 clone of neural stem cells (NSC) (Snyder et al.,
992, 1995, 1997), which can be easily infected by murine
etroviruses and was shown by others to function effec-
ively as a vehicle for bypassing the blood–brain barrier for
irus delivery into the brain (Lynch et al., 1996). The resultsndicated that by using this approach Fr54 was able to
0042-6822/99 $30.00
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24 POULSEN ET AL.ause CNS disease, and this disease appeared to be
orrelated with a marked increase in the number of infected
icroglial cells in the brain.
RESULTS
nfluence of route of inoculation on induction
f CNS disease
In these studies the two chimeric polytropic MuLV
lones, Fr54 and Fr98, were compared by IP inoculation
f cell-free virus and intraventricular inoculation of in-
ected NSC. The nonneurovirulent ecotropic Friend
uLV, clone FB29, which differed primarily in envelope
equences (Fig. 1), was used as a negative control (Por-
is et al., 1995). As noted previously (Hasenkrug et al.,
996; Robertson et al., 1997), after IP inoculation, only
r98 was able to induce CNS disease (Fig. 2). Ataxia was
pparent at 2 to 3 weeks postinfection, and mice were
sually moribund several days after initial symptoms
ppeared. No disease was induced by IP inoculation
ith Fr54 or FB29 (Hasenkrug et al., 1996; Portis et al.,
FIG. 1. Genetic structure of chimeric MuLV. Fr98 and Fr54 were gener
nto the ecotropic MuLV clone FB29 (Perryman et al., 1991; Portis et a
isease (Hasenkrug et al., 1996).
FIG. 2. Incidence of CNS disease in IRW mice. Mice were infected
noculation with infected NSC or uninfected NSC as controls (n). The pice per group were studied.995). In contrast, after intraventricular inoculation of
nfected NSC both Fr98 and Fr54 viruses caused clinical
NS disease. For both these viruses the symptomatol-
gy of the disease was similar to that seen after IP
noculation. Ataxia was evident between 1 and 2 weeks
fter infection with Fr98 and between 3 and 4 weeks after
nfection with Fr54 (Fig. 2), and mice died shortly there-
fter. In contrast, no clinical CNS disease was noted
fter intraventricular inoculation of uninfected NSC or
SC infected with FB29. Since Fr54 and FB29 differ
ainly in sequences of the envelope gene, these results
ndicate that compared to the nonneurovirulent FB29, the
r54 envelope does contain neurovirulence determi-
ants and is capable of inducing a brain disease similar
o Fr98 when inoculated by the appropriate route.
etection of virus p30 capsid protein
To determine if the neurological disease induced by
r54 in the above experiments was associated with an
ncrease in the level of virus within the CNS compared to
inserting the SphI to ClaI fragment from clones FMCF98 and FMCF54
; Hasenkrug et al., 1996). After IP inoculation only Fr98 induced CNS
r54 (E), Fr98 (F), or FB29 () virus via IP injection or intraventricular
ages of mice in each group exhibiting ataxia are shown. Fifteen to 20ated by
l., 1995with F
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25CNS RETROVIRAL INFECTIONP inoculated mice, we used quantitative antigen capture
LISA to examine viral capsid p30 protein levels in ho-
ogenates of the cerebrum and cerebellum of each
ouse. After IP inoculation, Fr98-infected mice had
lightly higher p30 levels in cerebra compared to Fr54-
nfected mice (Fig. 3). These differences were more strik-
ng in cerebella where 5 weeks after IP infection Fr54 still
id not reach the p30 levels seen with Fr98 at 2 weeks
Fig. 3). In contrast, in mice inoculated intraventricularly
ith Fr54-infected NSC, viral p30 levels in cerebra were
uch higher than seen after IP infection, suggesting that
ntraventricular infection with NSC was responsible for
his increase and that this might be important in the
nduction of CNS disease. Surprisingly, after intraventric-
lar infection with Fr54-infected cells, cerebral p30 val-
es exceeded levels seen with Fr98 in spite of the fact
hat Fr98-infected mice usually died 1 to 2 weeks earlier
Fig. 2). Thus, these differences in tempo of the disease
ould not be explained solely by the differences in the
30 levels observed. Furthermore, p30 levels were actu-
lly quite low in cerebella of mice inoculated intraven-
ricularly with Fr54-infected NSC, suggesting that this
oute of infection might have had a minimal effect on the
verall level of infection of the cerebellum. This finding
as consistent with the fact that the primary germinal
FIG. 3. Levels of virus p30 capsid protein in cerebrum and cerebell
apture ELISA. Open circles represent Fr54-infected mice, closed circ
ice. Geometric mean values plus or minus standard errors are pres
epresents time by which all mice had died.one of the neonatal cerebellum is the external granular mayer, which was not targeted by the NSC used in these
xperiments.
After intraventricular inoculation with NSC infected
ith the nonneurovirulent control virus FB29 extremely
igh viral p30 levels were seen in both cerebrum and
erebellum (Fig. 3). Thus a high level of MuLV infection in
rain per se was not sufficient for induction of CNS
isease, and the CNS disease induced by Fr54- or Fr98-
nfected NSC was dependent on the presence of the
olytropic MuLV envelope genes in these chimeric vi-
uses (Fig. 1).
mmunohistochemical localization of viral envelope
rotein
In previous studies using IP inoculation both Fr54
nd Fr98 were found to infect capillary endothelial
ells and cells resembling microglia within cerebellar
nd cerebral white matter, and to a lesser extent
ithin the thalamus and hippocampus (Robertson et
l., 1997). In order to determine whether introducing
r54 via intraventricular implantation of infected NSC
ltered the type or location of cells infected within the
rain we examined virus-infected cells by immunohis-
ochemical analysis. Following IP inoculation of Fr54,
1-week intervals p30 levels were determined by quantitative antigen
esent Fr98-infected mice, and open squares represent FB29-infected
for each group of three to nine animals per point. Dotted line and Xum. At
les repr
entedany infected cells in the cerebellum, thalamus, and
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26 POULSEN ET AL.nternal capsule were associated with the microvas-
ulature and appeared to consist of endothelial cells
nd perhaps perivascular microglia (Fig. 4). In the
erebellum some parenchymal cells were also virus-
ositive, and these appeared similar in location and
orphology to the cells identified previously to be
nfected microglia (Robertson et al., 1997). In contrast,
n mice inoculated intraventricularly with Fr54-infected
SC the predominant virus-positive cells in the cere-
ellum, thalamus, and internal capsule appeared to be
ighly arborized microglia, and only rarely were virus-
ositive microvascular cells found (Fig. 4). Therefore,
he CNS disease observed in mice inoculated with
r54-infected NSC correlated with an increase in the
umber of infected microglia in both the cerebrum and
he cerebellum (Fig. 4), even though the overall viral
oad in cerebellum did not appear to be increased (Fig.
FIG. 4. Immunohistochemical staining of Fr54-infected cells within th
sing either the IP route or intraventricular inoculation of infected NSC
iral envelope and a secondary peroxidase-conjugated rabbit anti-goat
AEC).). tMice inoculated intraventricularly with FB29-infected
SC had wide-spread brain infection of cells with highly
rborized processes that appeared to be microglia (data
ot shown). These cells were indistinguishable from
ells infected by Fr54 in mice inoculated intraventricu-
arly with infected NSC (Fig. 4). In addition, FB29 was
ble to infect high numbers of endothelial cells associ-
ted with the microvasculature. As shown in Fig. 3, the
verall viral p30 levels for FB29-infected mice were
igher than those seen in Fr54-infected mice. However,
n spite of these higher virus levels and infection in
imilar microglia-like cells, FB29 was unable to induce
ny clinical disease. Therefore, the sequence differ-
nces between Fr54 and FB29, which primarily were
ocated in the envelope gene (Fig. 5), appeared to en-
ode important neurovirulence differences between
ellum, thalamus, and internal capsule 3 weeks after infection by Fr54
ons were stained with a primary polyclonal goat antibody against the
y. Labeled cells were visualized with the substrate aminoethylcarbizole cereb
. Secti
antibodhese viruses.
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27CNS RETROVIRAL INFECTIONDISCUSSION
In the present experiments the “nonneurovirulent” vi-
us, Fr54, was found to have the potential to induce a
atal CNS disease similar to that induced by Fr98. This
isease was produced by intraventricular inoculation of
r54-infected NSC, an effective vehicle for disseminated
istribution of viruses throughout the CNS (Lynch et al.,
996). This method appeared to bypass the blood–brain
arrier (Snyder et al., 1995) and allowed Fr54 to infect
ncreased numbers of microglia in cerebellum, thalamus,
nternal capsule, and other regions of the brain. How-
ver, under these conditions, the tempo of disease in-
uced by Fr54 was still slower than that induced by Fr98,
uggesting that Fr54 probably has a lower intrinsic
athogenic potential than Fr98. Nevertheless, Fr54 was
learly more pathogenic than the ecotropic control virus,
lone FB29, which failed to induce any disease after
noculation by this route in spite of the high levels of viral
ntigen detected in brain (Fig. 3) and the widespread
nfection of microglia observed (data not shown).
The lower viral load seen in cerebellar extracts after
ntraventricular infection with Fr54- and Fr98-infected
ells (Fig. 3) did not correlate with the tempo of disease
nduction and appeared to suggest that the cerebellum
ight not be critically involved in the disease process.
owever, the immunohistochemical studies showed that
fter IP inoculation both capillary endothelial cells and
icroglial cells contributed to the overall viral load in the
erebella of these mice, whereas after intraventricular
noculation with infected NSC mainly microglia appeared
o be infected (Fig. 4). Thus the lower viral antigen levels
n the cerebella of these latter mice actually represented
igher numbers of infected microglia than after IP infec-
ion. Therefore increased microglial infection in both ce-
ebra and cerebella might be important in the disease
bserved in these mice.
FIG. 5. Effect of differences within the SphI to ClaI fragment on time
he SphI to ClaI fragments inserted into FB29 to generate Fr54 and Fr98
nv gene (all of SU plus most of TM). The env genes of FMCF54 (Koch e
or 39 pol, env, and 39 LTR sequence of FMCF98, clone 18-4) are naturall
nd an exogenous ecotropic Friend MuLV similar to FB29 (Perryman et a
r black bars in the figure. Within the SphI to ClaI fragment the amino a
5 of 232 residues, respectively, and these differences are concentrated
t 1–3 of 163 residues up to the ClaI site. The SU region of FB29 (Perry
r98, which differ from each other by only 54 of 440 amino acid residu
he difference between Fr54 and FB29 in induction of CNS disease afThe difference in CNS disease induction by NSC in- pected with Fr54 and FB29 appears to be mediated by
equences in the SphI to ClaI fragment used to generate
r54 (Figs. 1 and 5). The POL and TM sequences present
n this fragment are nearly identical in FB29 and Fr54, but
hese few amino acid differences might still be able to
nfluence neurovirulence. However, there are major se-
uence differences in the SU regions of these viruses,
hich would be more likely to be responsible for the
ifferences in neurovirulence observed, as has also
een suggested in an ecotropic MuLV system (Paquette
t al., 1989). Sequences in the variable VR-A and VR-B
egions of SU account for the difference in receptor
pecificity which distinguishes ecotropic from polytropic
uLVs (Battini et al., 1992), and these differences might
e critical for induction of the CNS disease seen in the
resent experiments. If so, perhaps the envelope of most
olytropic MuLVs could induce neurological disease if
xpressed at a high level in brain as in the present study;
owever, the SU sequences of both Fr54 and Fr98 might
e exceptional in their ability to induce CNS disease
ompared to other polytropic MuLVs. Studies with addi-
ional chimeric polytropic viruses will be required to
istinguish these possibilities.
The present results also extend previous data by in-
icating that the neurovirulence potential of Fr98 is
reater than that of Fr54 even when these viruses are
elivered by an efficient means which bypasses the
lood–brain barrier. The difference between these
lones is influenced by two separate areas of the SU
egion (Hasenkrug et al., 1996). One of these areas
ffects the number of microglia infected (Robertson et al.,
997) and the other affects the ability of the virus to
ndirectly induce neurotoxicity by infected microglia even
t relatively low levels of viral antigen expression in brain
Poulsen et al., 1998).
The effect of different regions of the viral envelope on
ction of CNS disease after inoculation by IP or intraventricular routes.
n sequences from the pol gene upstream of env, plus almost the entire
4) and FMCF98 (Portis et al., 1995) (Genbank Accession No. AF133256
d by recombination between endogenous polytropic MuLV sequences
). The approximate sites of recombination are indicated by the hatched
quence of the POL protein of Fr98 and Fr54 differ from FB29 at 17 and
of the start of the envelope gene. In the TM region these clones differ
al., 1991) is approximately 50% identical to the SU regions of Fr54 and
extensive differences in the SU region are most likely to account for
ulation of infected NSC as shown in the present report.of indu
contai
t al., 198
y derive
l., 1991
cid se
just 59
man et
es. Theathogenesis of CNS disease induced by polytropic
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28 POULSEN ET AL.uLVs may serve as a model for possible similar effects
f viral variation on the induction of HIV-induced brain
isease. Previous data indicates that the V1, V2, and V3
egions of the viral envelope may all contribute to neu-
opathogenesis. V3 is well known to influence tropism for
acrophages and microglia (Jordan et al., 1991), and V1
nd V2 may influence the level of replication or spread in
hese same cell types (Toohey et al., 1995; Power et al.,
998). Variations in V3 have also been shown to correlate
ith presence of dementia (Power et al., 1994), and
ecent data suggests that V3 sequences from the brains
f demented AIDS patients have an augmented ability to
nduce production of neurotoxic factors in infected mac-
ophages (Power et al., 1998). Thus many of these find-
ngs are quite similar to those in the Fr98 MuLV system,
nd it seems logical to expect that similar mechanisms
f pathogenesis may exist for both the murine and hu-
an retroviruses. The details of the pathogenic process
emains unclear in both of these systems, but the differ-
ntial production of neurotoxic factors by infected mac-
ophages or microglia in tissue cultures may provide a
ew opportunity to resolve these interesting questions.
MATERIALS AND METHODS
iruses
Virus stocks of infectious molecular clones were pre-
ared by transfecting mus dunni cells with retroviral DNA
xcised from plasmids generated as described previ-
usly (Hasenkrug et al., 1996). Stocks were supernatant
luids from cultures which were passaged 1 to 3 times
ntil they were confluently infected. Titers of stocks were
etermined by focal infectivity assay (Poulsen et al.,
998).
nfection of mice
Inbred Rocky Mountain White (IRW) mice were bred
nd housed at the Rocky Mountain Laboratories animal
acility. Within 24 h after birth, mice were infected by
ntraperitoneal (IP) injection with 105 focus forming units
FFU) of cell-free virus, or by intraventricular transplan-
ation of virus-infected NSC (clone C17.2). This clone
ntegrates seamlessly within the mature brain paren-
hyma throughout the neuraxis following engraftment
nto the germinal zones lining the cerebral ventricles of
he newborn mouse (Snyder et al., 1992, 1995, 1997). The
ells themselves cause no neurological symptoms, and
tructures to which they contribute are chimeric organs
ith normal development. Mice were observed daily for
igns of clinical disease, including ataxia, tremors, weak-
ess, and seizures, as previously described (Portis et al.,
995; Poulsen et al., 1998). All animal experiments were
one in accordance with standards established by the
ocky Mountain Laboratory Animal Care and Use Com-
ittee and the National Institutes of Health.C17.2 NSC were infected in vitro with Fr54, Fr98, or
B29 virus, and cultured until cells were confluently in-
ected as determined by indirect immunofluorescence
sing monoclonal antibody 514 reactive with Fr98 and
r54 or monoclonal antibody 48 reactive with FB29
Chesebro et al., 1983). A single cell suspension of in-
ected or uninfected NSC was prepared for transplanta-
ion, and 1–2 3 105 cells were injected into each lateral
entricle of cryoanesthetized neonatal mice as previ-
usly described (Lynch et al., 1996).
easurement of viral p30 antigen by antigen capture
LISA
At least three mice from each group were sacrificed at
-week intervals. Mice were anesthetized by isofluorane
nhalation and exsanguinated by severing the brachial
rtery. A 10% (w/v) homogenate was made of each brain,
nd viral p30 capsid protein levels were determined as
reviously described (Poulsen et al., 1998).
mmunohistochemistry
Two-and-a-half-week-old IRW mice were heavily anes-
hetized by isofluorane inhalation and perfused with 4%
ormaldehyde by transcardiac puncture. Brains were re-
oved and fixed for an additional 4 h in 4% formaldehyde
n PBS at 4°C. Paraffin-embedded brains were cut into
-mm sections, processed for antigen retrieval, and
tained for viral envelope protein as previously de-
cribed (Poulsen et al., 1998).
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